Source: The Bay Area Reporter
Dr. Jay Lalezri, Alan McCord, Dr. Lawrence Drew, Dr. Michael Harbour, and Dr. Marcus Conant discuss this year's flu season and the availability for HIV-positive people to enroll in a study for a new combination drug. Photo: Jane Philomen Cleland
“This flu season people living with HIV who contract influenza are being asked to test a new triple combination antiviral drug (TCAD) therapy that may work better in treating their symptoms and lessening the severity of their illness.
Anyone who is HIV-positive and experiencing flu-like symptoms, such as a fever of 100 degrees Fahrenheit or higher, headaches, or fatigue in combination with cough, sore throat, congestion, or muscle aches, can call a hotline to determine if they meet the criteria for the study.”
Click here to read more.
